Childhood Cancer

You are here

Home » Grants » All grants tagged with "Acute Myeloid Leukemia (AML)"

All grants tagged with "Acute Myeloid Leukemia (AML)"

Modeling Genetic Modifiers of Down Syndrome Leukemogenesis
Stella T. Chou, MD
Children’s Hospital of Philadelphia
Springboard Grants, Awarded 2013
Function of the PR Domain of the MDSI-EVI1 in MLL Fusion Protein Leukemogenesis
Archibald Perkins, MD, PhD
University of Rochester
Springboard Grants, Awarded 2013
Cooperating Genes for inv16 Acute Myeloid Leukemia
Lucio Castilla
University of Massachusetts Medical School
Bridge Grants, Awarded 2012
Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML
Roland Walter, MD, PhD
Fred Hutchinson Cancer Research Center
'A' Award Grants, Awarded 2012
Exploiting WT1 Genomic Alterations for Target Identification and MRD Monitoring in Pediatric AML
Phoenix Ho
Fred Hutchinson Cancer Research Center
Young Investigator Grants, Awarded 2012
Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia
Fabiana Ostronoff, MD
Fred Hutchinson Cancer Research Center
Young Investigator Grants, Awarded 2012
Selective inhibition of nuclear export as a novel therapeutic strategy in AML
Julia Etchin
Dana-Farber Cancer Institute
Young Investigator Grants, Awarded 2012
Targeting Neovascularization in Graft-Versus-Host Disease
Marcel van den Brink, MD/PhD
Memorial Sloan-Kettering Cancer Center
Innovation Grants, Awarded 2012
Modeling Pediatric Leukemia in the Zebrafish to Enable Discovery of New Anti-Leukemic Compounds
David Traver, MD
University of California, San Diego
Innovation Grants, Awarded 2012
Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen
David Pellman, MD
Dana-Farber Cancer Institute
Innovation Grants, Awarded 2012

Pages

All childhood cancer types

Featured Hero

Ailani Myers

Ailani's family calls her a true Warrior Princess as she fights acute lymphoblastic leukemia. Doctors discovered Ailani harbored a rare genetic mutation which makes standard treatment ineffective. Today, Ailani has reached remission!
Read more »